Dr. Fraker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
4 Silverstein Bldg
Philadelphia, PA 19104Phone+1 215-615-5858
Summary
- I am a Board certified general surgeon with almost 30 years of practice as an attending. I currently treat all surgical aspects of thyroid, parathyroid, and adrenal disease. I also operate on intra-abdominal and retroperitoneal sarcomas as well as neuroendocrine tumors of the pancreas and small bowel. I will also operate on primary metastatic tumors to the liver as well as adenocarcinoma of the pancreas as well as the biliary system.
Education & Training
- University of California (San Francisco)Residency, Surgery, 1989 - 1991
- Clinical Center at the National Institutes of HealthResidency, Surgery, 1986 - 1989
- University of California (San Francisco)Residency, Surgery, 1983 - 1986
- Harvard Medical SchoolClass of 1983
Certifications & Licensure
- CA State Medical License 1984 - Present
- PA State Medical License 1995 - 2024
- NJ State Medical License 2017 - 2021
- FL State Medical License 2018 - 2020
- MD State Medical License 1986 - 1996
Awards, Honors, & Recognition
- Philadelphia Magazine Castle Connolly, 2004-2014
- America's Top Doctors Castle Connolly, 2003-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Join now to see all
Clinical Trials
- Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma of the Arm or Leg Start of enrollment: 1999 Mar 01
Publications & Presentations
PubMed
- Recurrence and treatment trends of pancreatic neuroendocrine tumors.Amanda Bader, Sarah Landau, Jasmine Hwang, Jesse Passman, Major Kenneth Lee
Surgery. 2025-01-01 - Predicting cure and hypocalcemia by intraoperative parathyroid hormone decline in normohormonal primary hyperparathyroidism: A multi-institutional validation study.Timothy Kravchenko, Caitlin B Finn, Douglas L Fraker, Rachel R Kelz, Carrie Cunningham
Surgery. 2025-01-01 - Contemporary trends in utilization of metastasectomy in the era of targeted and immunotherapies.Jesse E Passman, Michael J Kallan, Jeffrey L Roberson, Sara P Ginzberg, Wajid Amjad
Cancer. 2024-12-11
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: